Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose then the missed dose can be skipped. Do not take a double dose to make up for the missed one.
Seek emergency medical treatment or contact the doctor in case of an overdose.
Amitriptyline (moderate)
Tramadol (severe)
Pimozide (severe)
Selegiline (severe)
Formoterol (moderate)
Epinephrine (moderate)
Phenylephrine (moderate)
Methylene (severe)
Bupropion (severe)
Clonidine (moderate)
Linezolid (severe)
Salbutamol (moderate)
This medicine is used for the treatment of attention-deficit hyperactive disorder in children and adults. This medicine may improve focus and decrease impulsivity and hyperactive behavior. It should only be used for children above 6 years of age and for adults up to 65 years of age.
This medicine is used for the treatment of narcolepsy, a sleep disorder that causes excessive daytime sleepiness and sudden attacks of sleep.
Nervousness
Difficulty in falling or staying asleep
Dizziness and Drowsiness
Nausea and Vomiting
Loss of appetite
Stomach pain
Diarrhea
Heartburn
Uncontrolled muscle movements
Burning, numbness, tingling in the arms and feet
Fast/irregular heart beat
Chest pain
Shortness of breath
Excessive tiredness
Slurred speech (rare)
Blurred vision
Frequent, painful erections (rare)
Skin Rash (rare)
Blistering and peeling of skin (rare)
Swelling of the face, lips, or tongue (rare)
Blood in urine and stools
Unusual bleeding or bruising (rare)
This medicine is not recommended for use in patients with a known allergy to FANIDAN 10mg Tablet 3×10 or any other inactive ingredients present in the formulation.
This medicine is not recommended for use in patients with marked anxiety, tension, and agitation due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with glaucoma due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with motor tics or in patients with a family history of diagnosis of Tourette's syndrome due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients undergoing treatment with monoamine oxidase inhibitors (MAOIs) such as selegiline, moclobemide etc. There should be a time gap of at least 14 days between stopping treatment with MAOIs and beginning treatment with this medicine to avoid their interaction.